3,309
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Effect of blood pressure variability on hypertensive retinopathy

ORCID Icon, &
Article: 2205050 | Received 08 Dec 2022, Accepted 14 Apr 2023, Published online: 30 Apr 2023

References

  • Kim HC, Jeon YW, Heo ST. Global impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines. Circulation. 2018;138(21):2312–9. doi:10.1161/CIRCULATIONAHA.118.036312.
  • Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020 Jun;38(6):982–1004. doi:10.1097/HJH.0000000000002453.
  • Xiong H, Wu D, Tian X, Lin WH, Li C, Zhang H, Cai Y, Zhang Y-T. The relationship between the 24 h blood pressure variability and carotid intima-media thickness: a compared study. Comput Math Methods Med. 2014;2014:303159. doi:10.1155/2014/303159.
  • Park CH, Kim HW, Joo YS, Park JT, Chang TI, Yoo TH, Park SK, Chae D-W, Chung W, Kim Y-S, et al. on the behalf of the KNOW‐CKD (Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease) Investigators. Association between systolic blood pressure variability and major adverse cardiovascular events in Korean Patients with Chronic Kidney Disease: findings from KNOW-CKD. J Am Heart Assoc. 2022; 11(11):e025513. doi:10.1161/JAHA.122.025513.
  • Triantafyllidi H, Benas D, Schoinas A, Birmpa D, Trivilou P, Varytimiadi E, Voutsinos D, Ikonomidis I. Hypertension-mediated organ damage regression associates with blood pressure variability improvement three years after successful treatment initiation in essential hypertension. J Clin Hypertens (Greenwich). 2021;23(6):1150–58. doi:10.1111/jch.14209.
  • Gutteridge DS, Tully PJ, Ghezzi ES, Jamadar S, Smith AE, Commerford T, Keage HAD. Blood pressure variability and structural brain changes: a systematic review. J Hypertens. 2022;40(6):1060–70. doi:10.1097/HJH.0000000000003133.
  • Mena L, Pintos S, Queipo NV, Aizpúrua JA, Maestre G, Sulbarán T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23(3):505–11. doi:10.1097/01.hjh.0000160205.81652.5a.
  • Wong TY, Klein R, Nieto FJ, Klein BE, Sharrett AR, Meuer SM, Hubbard LD, Tielsch JM. Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology. 2003;110(5):933–40. doi:10.1016/S0161-6420(03)00084-8.
  • McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE, Wang JJ, Mitchell P, Vingerling JR, de Jong PTVM, et al. Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol. 2009;170(11):1323–32. doi:10.1093/aje/kwp306.
  • Arnould L, Binquet C, Guenancia C, Alassane S, Kawasaki R, Daien V, Tzourio C, Kawasaki Y, Bourredjem A, Bron A, et al. Association between the retinal vascular network with Singapore “I” Vessel Assessment (SIVA) software, cardiovascular history and risk factors in the elderly: the Montrachet study, population-based study. PLoS One. 2018;13(4):e0194694. doi:10.1371/journal.pone.0194694.
  • Arnould L, Guenancia C, Azemar A, Alan G, Pitois S, Bichat F, Zeller M, Gabrielle P-H, Bron AM, Creuzot-Garcher C, et al. The EYE-MI pilot study: a prospective acute coronary syndrome cohort evaluated with retinal optical coherence tomography angiography. Invest Ophthalmol Visual Sci. 2018;59(10):4299–306. doi:10.1167/iovs.18-24090.
  • Shin YI, Nam KY, Lee WH, Ryu CK, Lim HB, Jo YJ, Kim J-Y. Peripapillary microvascular changes in patients with systemic hypertension: an optical coherence tomography angiography study. Sci Rep. 2020;10(1):6541. doi:10.1038/s41598-020-63603-6.
  • Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis.Am. J Med Sci. 1974;6:336–45. Doi:10.1097/00000441-197412000-00004.
  • Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004;351(22):2310–17. doi:10.1056/NEJMra032865.
  • Kashani AH, Chen CL, Gahm JK, Zheng F, Richter GM, Rosenfeld PJ, Shi Y, Wang RK. Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications. Prog Retin Eye Res. 2017;60:66–100. doi:10.1016/j.preteyeres.2017.07.002.
  • Mena LJ, Felix VG, Melgarejo JD, Maestre GE. 24-hour blood pressure variability assessed by average real variability: a systematic review and meta-analysis. J Am Heart Assoc. 2017;6(10):e006895. doi:10.1161/JAHA.117.006895.
  • Yamaguchi Y, Wada M, Sato H, Nagasawa H, Koyama S, Takahashi Y, Kawanami T, Kato T. Impact of ambulatory blood pressure variability on cerebral small vessel disease progression and cognitive decline in community-based elderly Japanese. Am J Hypertens. 2014;27(10):1257–67. doi:10.1093/ajh/hpu045.
  • Mulè G, Calcaterra I, Costanzo M, Morreale M, D’Ignoto F, Castiglia A, Geraci G, Rabbiolo G, Vaccaro F, Cottone S. Average real variability of 24-h systolic blood pressure is associated with microalbuminuria in patients with primary hypertension. J Hum Hypertens. 2016;30(3):164–70. doi:10.1038/jhh.2015.66.
  • Hsu PF, Cheng HM, Wu CH, Sung SH, Chuang SY, Lakatta EG, Yin FCP, Chou P, Chen C-H. High short-term blood pressure variability predicts long-term cardiovascular mortality in untreated hypertensives but not in normotensives. Am J Hypertens. 2016;29(7):806–13. doi:10.1093/ajh/hpw002.
  • Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, et al. International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension. 2010 Apr;55(4):1049–57. doi:10.1161/HYPERTENSIONAHA.109.140798.
  • Parati G, Stergiou GS, Dolan E, Bilo G. Blood pressure variability: clinical relevance and application. J Clin Hypertens (Greenwich). 2018;20(7):1133–37. doi:10.1111/jch.13304.
  • Middeke M. [Blood pressure variability]. Dtsch Med Wochenschr. 2011;136(46):2361–66. doi:10.1055/s-0031-1292052.
  • Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375(9718):938–48. doi:10.1016/S0140-6736(10)60309-1.
  • Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol (1985). 2008;105(5):1652–60. doi:10.1152/japplphysiol.90549.2008.
  • Eto M, Toba K, Akishita M, Kozaki K, Watanabe T, Kim S, HASHIMOTO M, SUDOH N, YOSHIZUMI M, OUCHI Y. Reduced endothelial vasomotor function and enhanced neointimal formation after vascular injury in a rat model of blood pressure lability. Hypertens Res. 2003;26(12):991–98. doi:10.1291/hypres.26.991.
  • Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, Ota M, Nagai K, Araki T, Satoh H, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension. 2000;36(5):901–06. doi:10.1161/01.HYP.36.5.901.
  • Tang Q, Zhang Y, Yang Z, Li S, Wu M, Guo Y, Zhao W, Yin C. Study on the interaction between the characteristics of retinal microangiopathy and risk factors for cerebral small vessel disease. Contrast Media Mol Imaging. 2022;2022:9505945. doi:10.1155/2022/9505945.
  • Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Tielsch JM, Klein BE, Hubbard LD. Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA. 2002;287(9):1153–59. doi:10.1001/jama.287.9.1153.
  • Wong TY, Rosamond W, Chang PP, Couper DJ, Sharrett AR, Hubbard LD, Folsom AR, Klein R. Retinopathy and risk of congestive heart failure. JAMA. 2005;293(1):63–69. doi:10.1001/jama.293.1.63.
  • Liew G, Wong TY, Mitchell P, Cheung N, Wang JJ. Retinopathy predicts coronary heart disease mortality. Heart. 2009;95(5):391–94. doi:10.1136/hrt.2008.146670.
  • Chua J, Le TT, Sim YC, Chye HY, Tan B, Yao X, Wong D, Ang BWY, Toh D-F, Lim H, et al. Relationship of quantitative retinal capillary network and myocardial remodeling in systemic hypertension. J Am Heart Assoc. 2022;11(6):e024226. doi:10.1161/JAHA.121.024226.
  • Anjos R, Ferreira A, Barkoudah E, Claggett B, Abegão Pinto L, Miguel A. Application of optical coherence tomography angiography macular analysis for systemic hypertension. a systematic review and meta-analysis. Am J Hypertens. 2022;35(4):356–64. doi:10.1093/ajh/hpab172.
  • Donati S, Maresca AM, Cattaneo J, Grossi A, Mazzola M, Caprani SM, Premoli L, Docchio F, Rizzoni D, Guasti L, et al. Optical coherence tomography angiography and arterial hypertension: a role in identifying subclinical microvascular damage? Eur J Ophthalmol. 2021;31(1):158–65. doi:10.1177/1120672119880390.
  • Chua J, Chin CWL, Hong J, Chee ML, Le TT, Wong TY, Schmetterer L, Schmetterer L. Impact of hypertension on retinal capillary microvasculature using optical coherence tomographic angiography. J Hypertens. 2019;37(3):572–80. doi:10.1097/HJH.0000000000001916.
  • Chua J, Chin CWL, Tan B, Wong SH, Devarajan K, Le TT, Ang M, Wong TY, Schmetterer L. Impact of systemic vascular risk factors on the choriocapillaris using optical coherence tomography angiography in patients with systemic hypertension. Sci Rep. 2019;9(1):5819. doi:10.1038/s41598-019-41917-4.
  • Hua D, Xu Y, Zeng X, Yang N, Jiang M, Zhang X, Yang J, He T, Xing Y. Use of optical coherence tomography angiography for assessment of microvascular changes in the macula and optic nerve head in hypertensive patients without hypertensive retinopathy. Microvasc Res. 2020;129:103969. doi:10.1016/j.mvr.2019.103969.
  • Triantafyllou A, Anyfanti P, Pyrpasopoulou A, Triantafyllou G, Aslanidis S, Douma S. Capillary rarefaction as an index for the microvascular assessment of hypertensive patients. Curr Hypertens Rep. 2015;17(5):33. doi:10.1007/s11906-015-0543-3.
  • Prewitt RL, Chen II, Dowell R. Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol. 1982;243(2):H243–51. doi:10.1152/ajpheart.1982.243.2.H243.
  • Bursali Ö, Altintaş Ö, Ağir A, Yüksel N, Özkan B. Optical coherence tomography measurements in patients with systemic hypertension. Scott Med J. 2021;66(3):115–21. doi:10.1177/00369330211011175.
  • Aflyatumova GN, Nigmatullina RR, Sadykova DI, Chibireva MD, Fugetto F, Serra R. Endothelin-1, nitric oxide, serotonin and high blood pressure in male adolescents. Vasc Health Risk Manag. 2018;14:213–23. doi:10.2147/VHRM.S170317.
  • Luo X, Shen YM, Jiang MN, Lou XF, Shen Y. Ocular blood flow autoregulation mechanisms and methods. J Ophthalmol. 2015;2015:864871. Doi:10.1155/2015/864871.
  • Rossignol P, Hosseini K, Tropeano AI, Fay R, Tsatsaris A, Guillemin F, Mounier-Vehier C. Target organ damage assessment in French hypertensive patients without established cardiovascular or renal disease: results of the PREVENT-A study. J Hypertens. 2013;31(1):177–85. doi:10.1097/HJH.0b013e32835a34bb.
  • Harbaoui B, Courand PY, Defforges A, Khettab F, Milon H, Girerd N, Lantelme P. cumulative effects of several target organ damages in risk assessment in hypertension. Am J Hypertens. 2016;29(2):234–44. doi:10.1093/ajh/hpv098.
  • Sairenchi T, Iso H, Yamagishi K, Irie F, Okubo Y, Gunji J, Muto T, Ota H. Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study. Circulation. 2011;124(23):2502–11. doi:10.1161/CIRCULATIONAHA.111.049965.
  • Hughes AD, Stanton AV, Jabbar AS, Chapman N, Martinez-Perez ME, McG Thom SA. Effect of antihypertensive treatment on retinal microvascular changes in hypertension. J Hypertens. 2008;26(8):1703–07. doi:10.1097/HJH.0b013e328304b072.
  • Bosch A, Scheppach JB, Harazny JM, Raff U, Eckardt KU, Schmieder RE, Schneider MP. Retinal capillary and arteriolar changes in patients with chronic kidney disease. Microvasc Res. 2018;118:121–27. doi:10.1016/j.mvr.2018.03.008.